| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,573 |
2,401 |
$1.05M |
| 97162 |
|
693 |
452 |
$70K |
| 97161 |
|
602 |
418 |
$61K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,064 |
805 |
$59K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,716 |
2,297 |
$50K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,693 |
2,280 |
$50K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,823 |
1,504 |
$39K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,560 |
3,815 |
$30K |
| 71046 |
Radiologic examination, chest; 2 views |
2,585 |
1,851 |
$27K |
| 80053 |
Comprehensive metabolic panel |
5,986 |
4,938 |
$26K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
315 |
157 |
$25K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,637 |
536 |
$25K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
334 |
135 |
$24K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,707 |
1,413 |
$22K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
2,071 |
1,782 |
$18K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
114 |
71 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,812 |
5,528 |
$16K |
| 87631 |
|
383 |
294 |
$14K |
| 86780 |
|
1,831 |
1,502 |
$13K |
| 87430 |
|
2,205 |
2,065 |
$11K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
767 |
241 |
$11K |
| 80061 |
Lipid panel |
4,158 |
3,614 |
$10K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
745 |
694 |
$10K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
294 |
272 |
$9K |
| 87653 |
|
439 |
392 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,135 |
1,835 |
$9K |
| 87808 |
|
1,161 |
958 |
$9K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
179 |
148 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
2,113 |
1,447 |
$7K |
| 87081 |
|
2,855 |
2,512 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
751 |
658 |
$6K |
| 87340 |
|
1,213 |
979 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,656 |
1,386 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,479 |
2,191 |
$6K |
| 86803 |
|
862 |
680 |
$6K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
491 |
433 |
$6K |
| 82607 |
|
947 |
805 |
$5K |
| 84439 |
|
1,289 |
1,105 |
$5K |
| 85027 |
|
1,901 |
1,546 |
$5K |
| 83655 |
|
570 |
528 |
$5K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,305 |
1,012 |
$4K |
| 73630 |
|
422 |
367 |
$4K |
| 97163 |
|
41 |
24 |
$4K |
| 72110 |
|
220 |
203 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
252 |
158 |
$4K |
| 86480 |
|
147 |
115 |
$3K |
| 73610 |
|
235 |
208 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
147 |
92 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
368 |
323 |
$3K |
| 87186 |
|
503 |
440 |
$3K |
| 87205 |
|
1,368 |
1,127 |
$2K |
| 73130 |
|
261 |
182 |
$2K |
| 84466 |
|
565 |
488 |
$2K |
| 87581 |
|
114 |
71 |
$2K |
| 87486 |
|
114 |
71 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
21 |
21 |
$2K |
| 86038 |
|
281 |
199 |
$2K |
| 81001 |
|
1,615 |
1,358 |
$2K |
| 82728 |
|
542 |
464 |
$2K |
| 73030 |
|
159 |
146 |
$2K |
| 86850 |
|
819 |
681 |
$2K |
| 82570 |
|
864 |
748 |
$2K |
| 83540 |
|
578 |
496 |
$2K |
| 73110 |
|
151 |
119 |
$2K |
| 86140 |
|
727 |
537 |
$2K |
| 86762 |
|
589 |
509 |
$2K |
| 86901 |
|
827 |
688 |
$1K |
| 82043 |
|
781 |
678 |
$1K |
| 73560 |
|
131 |
101 |
$1K |
| 82950 |
|
605 |
553 |
$1K |
| 85652 |
|
955 |
710 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
40 |
28 |
$1K |
| 86900 |
|
832 |
693 |
$992.19 |
| 84450 |
|
435 |
357 |
$911.56 |
| 86003 |
|
97 |
66 |
$873.15 |
| 81003 |
|
963 |
809 |
$790.16 |
| 73564 |
|
76 |
54 |
$775.22 |
| 85610 |
|
474 |
296 |
$742.52 |
| 84460 |
|
346 |
280 |
$733.35 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16 |
13 |
$700.03 |
| 82746 |
|
121 |
105 |
$616.95 |
| 84481 |
|
127 |
103 |
$609.76 |
| 84403 |
|
31 |
27 |
$578.78 |
| 84702 |
|
172 |
110 |
$576.96 |
| 86431 |
|
154 |
97 |
$504.85 |
| 80076 |
|
145 |
121 |
$478.94 |
| 86706 |
|
73 |
60 |
$477.68 |
| 82951 |
|
85 |
74 |
$467.41 |
| 73140 |
|
56 |
52 |
$386.66 |
| 87088 |
|
77 |
71 |
$380.31 |
| 83516 |
|
41 |
31 |
$355.50 |
| 73562 |
|
35 |
30 |
$353.88 |
| 83735 |
|
114 |
82 |
$352.08 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
36 |
28 |
$347.18 |
| 85018 |
|
285 |
205 |
$295.07 |
| 82784 |
|
43 |
30 |
$283.96 |
| 84703 |
|
86 |
70 |
$283.83 |
| 81025 |
|
339 |
310 |
$275.92 |
| 81002 |
|
245 |
228 |
$259.44 |
| 85014 |
|
231 |
167 |
$241.75 |
| 83001 |
|
29 |
24 |
$238.69 |
| 73502 |
|
17 |
16 |
$181.28 |
| 87147 |
|
107 |
88 |
$157.56 |
| 74018 |
|
14 |
14 |
$142.39 |
| 82565 |
|
59 |
52 |
$141.27 |
| 84153 |
|
21 |
12 |
$135.55 |
| 86200 |
|
26 |
15 |
$132.35 |
| 86704 |
|
18 |
13 |
$122.24 |
| 84165 |
|
16 |
13 |
$76.65 |
| 80050 |
General health panel |
42 |
31 |
$74.55 |
| 82785 |
|
29 |
24 |
$73.89 |
| 86787 |
|
15 |
13 |
$58.40 |
| 82952 |
|
30 |
30 |
$50.22 |
| 85730 |
|
12 |
12 |
$31.62 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
46 |
13 |
$28.34 |
| 81015 |
|
15 |
13 |
$16.51 |
| 84156 |
|
14 |
13 |
$14.56 |
| 87077 |
|
56 |
55 |
$0.00 |
| 87106 |
|
313 |
303 |
$0.00 |